| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.57▲ | 1.56▲ | 1.56▲ | 1.66▼ | 1.87▼ |
| MA10 | 1.59▲ | 1.61▼ | 1.61▼ | 1.71▼ | 2.03▼ |
| MA20 | 1.65▼ | 1.68▼ | 1.68▼ | 1.85▼ | 2.52▼ |
| MA50 | 1.70▼ | 1.71▼ | 1.74▼ | 2.03▼ | 2.15▼ |
| MA100 | 1.77▼ | 1.84▼ | 1.88▼ | 2.49▼ | 2.41▼ |
| MA200 | 1.92▼ | 1.97▼ | 2.00▼ | 2.13▼ | 2.53▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | -0.012▼ | -0.009▼ | -0.015▼ | -0.142▼ |
| RSI | 41.138▼ | 40.658▼ | 41.085▼ | 32.077▼ | 37.331▼ |
| STOCH | 23.418 | 16.190▼ | 16.163▼ | 23.837 | 7.172▼ |
| WILL %R | -68.421 | -76.000▼ | -78.182▼ | -91.071▼ | -98.221▼ |
| CCI | -36.190 | -56.801 | -56.893 | -149.118▼ | -95.251 |
|
Thursday, October 30, 2025 05:20 AM
Celularity (CELU) announced a strategic partnership with DefEYE, a newly established ophthalmic product and technology company. Celularity has ...
|
|
Thursday, October 30, 2025 12:00 AM
DefEYE’s leadership includes key personnel from the original Verséa Ophthalmics team, ensuring continuity of expertise and relationships in the rapidly evolving eye care market. Celularity has the ...
|
|
Tuesday, October 14, 2025 01:45 AM
As a qualified stem cell therapy under Florida statute (§ 458.3245), effective July 1, 2025 authorizing use in wound care, orthopedics, and pain management, PDA-002 may offer licensed Florida ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 1.62 | 1.62 | 1.50 | 1.55 | 137,656 |
| 13/11/25 | 1.69 | 1.7149 | 1.59 | 1.59 | 93,573 |
| 12/11/25 | 1.75 | 1.75 | 1.60 | 1.68 | 61,937 |
| 11/11/25 | 1.746 | 1.79 | 1.60 | 1.72 | 79,623 |
| 10/11/25 | 1.751 | 1.83 | 1.73 | 1.77 | 65,859 |
| 07/11/25 | 1.716 | 1.7859 | 1.66 | 1.78 | 64,175 |
| 06/11/25 | 1.86 | 1.8809 | 1.6539 | 1.69 | 72,880 |
| 05/11/25 | 1.72 | 1.85 | 1.64 | 1.84 | 35,292 |
| 04/11/25 | 1.73 | 1.74 | 1.62 | 1.72 | 67,161 |
| 03/11/25 | 1.90 | 1.90 | 1.70 | 1.72 | 123,036 |
|
|
||||
|
|
||||
|
|